Avid Bioservices Inc (CDMO)

[biopharm]

It would be nice if Ronin Capital Mandated actually took it a step further and give a specific example of the BOD of a company not taking proper steps following fiduciary duty like Medarex did and not getting a competitive bid not even requesting Goldman Sachs to get a competitive bid for them when they had that set up sale to Bristol Myers Squibb

"
Goldman Sachs' Letter to MEDX Board of Directors (BOD) OPENLY Acknowledges that MEDX BOD Failed to Perform Its Fiduciary Responsibilities.... "
...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133652618

This is important because it would prove Ronin Capital Management is thinking ahead and trying to ensure shareholders what their intentions truly are....and make not of how important it is to unveil BEFORE any sale or transfer at anytime....of ALL collaborations from the past to present and go after IP rights of royalties for ANY patents that were filed possibly based on new knowledge and ideas or Biomarkers....etc etc based upon now known, non-obvious knowledge or ideas or Biomarkers etc etc....that is duly the right of PS Targeting patent holders....the shareholders of Peregrine Pharmaceuticals.

This is a start and would secure a hell of a lot more votes for Ron in group....and with better ideas to add, they could succeed easily.

I dont believe they would do this ....but if so, we know things will become interesting at that time ...